While that is less than the $1.03 billion the EV maker had said it was aiming to raise in its regulatory filings last week, the IPO would still be the city’s largest this year. It had planned to raise $1.5 billion but cut the size after a lukewarm response from investors.
The sources spoke on condition of anonymity as the pricing information was not public. Leapmotor declined to comment.
The pricing revealed on Sunday is at the bottom of the range of HK$48 to HK$62 a share that Leapmotor has set for the 130.82-million-share deal.
Potential investors cut back their orders amid volatility in global financial markets, one source said.
In the United States, the S&P500 dropped 4.7% last week as the Federal Reserve raised interest rates and markets remained concerned about high inflation. Hong Kong’s Hang Seng Index fell 4.4%, its worst for 10 weeks.
Discover the stories of your interest
Leapmotor, based in Hangzhou, produces four EV models that mainly target China’s middle and lower-end mass market in a 79,500-300,000 yuan ($11,500-$43,000) price range, according to its website and prospectus filed with the Hong Kong Stock Exchange.
It plans to use the IPO funds for research and development and to boost its production capacity and sales network, according to regulatory filings.
Chinese battery maker CALB is raising up to $1.7 billion in an IPO, according to a company statement, in a deal that would eclipse Leapmotor and make it the biggest new share sale in Hong Kong in 2022.
Hong Kong IPO volumes have fallen nearly 90% as global markets remain roiled by China regulatory uncertainty, rising interest rates, high inflation and the Russia’s war in Ukraine.
Despite the Leapmotor and CALB deals, plus China Vanke’s property services unit Onewo Inc raising $733 million, dealmakers are cautious there will be a solid rebound in new share sales in Hong Kong and overseas before 2023.
“It feels that these IPOs are kind of one-off transactions and think the Hong Kong market is not yet fully opened up,” said Shifara Samsudeen, LightStream Research analyst who publishes on Smartkarma.
“Most of the deals were downsized,” she said. “There have been long gaps between a hearing approval to pre-marketing and listing, these all suggest that the market is yet to return to normalcy.”
